Eris Lifesciences Limited — Call Transcript 2024

Oct 25, 2024

==> picture [596 x 137] intentionally omitted <==

Date: 24 October 2024

To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai- 400001 Bandra (E) Mumbai-400051 Security Code: 540596/975731/975732 Symbol: ERIS

SUBJECT: RECORDING OF THE EARNINGS CONFERENCE CALL ON THE UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS OF THE COMPANY FOR THE QUARTER AND HALF YEAR ENDED SEPTEMBER 30, 2024

Dear Sir/Madam,

In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we hereby inform you that the Recording of the Earnings Conference Call in connection with the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024, held on October 25, 2024, is available on the website of the Company and can be accessed through the following link:

Link: https://eris.co.in/financials/

(File name: Q2 FY25-Earnings Call Recording)

Thanking You,

For Eris Lifesciences Limited Milind Digitally signed by Milind Talegaonkar DN: cn=Milind Talegaonkar, o=Eris Lifesciences Limited, ou, Talegaonk email=complianceofficer@erislife sciences.com, c=IN ar Date: 2024.10.25 19:09:05 +05'30' ____________________ Milind Talegaonkar Company Secretary & Compliance Officer ICSI Mem. No.: A26493

==> picture [595 x 73] intentionally omitted <==